Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

Key details about PCI after TAVR | Cardiology groups oppose Medicaid cuts | Semaglutide works fast | Reframing leadership myths

News You Need to Know Today
Key details about PCI after TAVR | Cardiology groups oppose Medicaid cuts | Semaglutide works fast | Reframing leadership myths
Thursday, May 15, 2025
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

PCI just as successful when patients have a history of TAVR—but there are some added risks

Strokes and bleeding complications are more likely when PCI patients have already undergone TAVR, according to a new analysis of ACC registry data.

READ MORE >
PCI interventional cardiology. The use of radial access during PCI procedures is increasing throughout the United States, and new data presented at the SCAI's annual meeting suggest that could be beneficial for patients. 
Share on Twitter Share on Facebook Share on Linkedin

PCI just as successful when patients have a history of TAVR—but there are some added risks

Share on Twitter Share on Facebook Share on Linkedin
PCI interventional cardiology. The use of radial access during PCI procedures is increasing throughout the United States, and new data presented at the SCAI's annual meeting suggest that could be beneficial for patients. 
Strokes and bleeding complications are more likely when PCI patients have already undergone TAVR, according to a new analysis of ACC registry data.
READ MORE >

Cardiology groups among the many voices asking Congress not to cut Medicaid

More than 40 U.S. healthcare organizations are urging Congress not to make sweeping Medicaid cuts that could result in approximately 7.6 million Americans losing health insurance.

READ MORE >
Kit Crancer, chair of the Radiology Business Management Association Radiology (RBMA) Patient Action Network, and senior vice president of public policy for Rayus, explains RBMA's concerns over how the Trump administration's $1 trillion in cuts to Medicaid will economically impact rural hospitals.
Share on Twitter Share on Facebook Share on Linkedin

Cardiology groups among the many voices asking Congress not to cut Medicaid

Share on Twitter Share on Facebook Share on Linkedin
Kit Crancer, chair of the Radiology Business Management Association Radiology (RBMA) Patient Action Network, and senior vice president of public policy for Rayus, explains RBMA's concerns over how the Trump administration's $1 trillion in cuts to Medicaid will economically impact rural hospitals.
More than 40 U.S. healthcare organizations are urging Congress not to make sweeping Medicaid cuts that could result in approximately 7.6 million Americans losing health insurance.
READ MORE >

Semaglutide works fast, protecting the heart before weight loss kicks in

"These results highlight semaglutide’s early action on decreasing major cardiovascular events," one cardiologist explained.

READ MORE >
Semaglutide (Wegovy) injector pen. Photo by Dave Fornell
Share on Twitter Share on Facebook Share on Linkedin

Semaglutide works fast, protecting the heart before weight loss kicks in

Share on Twitter Share on Facebook Share on Linkedin
Semaglutide (Wegovy) injector pen. Photo by Dave Fornell
"These results highlight semaglutide’s early action on decreasing major cardiovascular events," one cardiologist explained.
READ MORE >

Guest Commentary

It may not be easy, but it changes lives: Reframing myths of healthcare leadership

Leadership is not easy, but it is worth doing. According to one seasoned healthcare executive, the world needs more physicians to move into leadership positions.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

It may not be easy, but it changes lives: Reframing myths of healthcare leadership

Share on Twitter Share on Facebook Share on Linkedin
Leadership is not easy, but it is worth doing. According to one seasoned healthcare executive, the world needs more physicians to move into leadership positions.
READ MORE >

Featured Articles

FDA approves popular ultrasound enhancing agent for pediatric patients

Unlike other UEA options, GE HealthCare's Optison does not contain polyethylene glycol. The FDA approved its use for adult patients back in 1997.

READ MORE >
GE HealthCare Optison ultrasound enhancing agent used to enhance otherwise suboptimal echocardiograms and better show the borders of the chambers of the heart.
Share on Twitter Share on Facebook Share on Linkedin

FDA approves popular ultrasound enhancing agent for pediatric patients

Share on Twitter Share on Facebook Share on Linkedin
GE HealthCare Optison ultrasound enhancing agent used to enhance otherwise suboptimal echocardiograms and better show the borders of the chambers of the heart.
Unlike other UEA options, GE HealthCare's Optison does not contain polyethylene glycol. The FDA approved its use for adult patients back in 1997.
READ MORE >

New drug for obstructive HCM outperforms the current standard of care

Cytokinetics announced positive results from a new clinical trial comparing aficamten monotherapy to the beta blocker metoprolol.

READ MORE >
Many attendees shot selfies in front of the the massive heart on display in the Cytokinetic booth at AHA 2022.
Share on Twitter Share on Facebook Share on Linkedin

New drug for obstructive HCM outperforms the current standard of care

Share on Twitter Share on Facebook Share on Linkedin
Many attendees shot selfies in front of the the massive heart on display in the Cytokinetic booth at AHA 2022.
Cytokinetics announced positive results from a new clinical trial comparing aficamten monotherapy to the beta blocker metoprolol.
READ MORE >

Cardiologist highlights safety, effectiveness of Boston Scientific TAVR valve

Andreas Ruck, MD, discussed new registry data on Boston Scientific’s Acurate neo2 TAVR valve, comparing it to popular devices from Edwards Lifesciences and Medtronic.

READ MORE >
Video interview with Andreas Ruck, MD, explaining a SWEDHEART registry comparison of Acurate Neo2 to Sapien and Evolut TAVR valves.
Share on Twitter Share on Facebook Share on Linkedin

Cardiologist highlights safety, effectiveness of Boston Scientific TAVR valve

Share on Twitter Share on Facebook Share on Linkedin
Video interview with Andreas Ruck, MD, explaining a SWEDHEART registry comparison of Acurate Neo2 to Sapien and Evolut TAVR valves.
Andreas Ruck, MD, discussed new registry data on Boston Scientific’s Acurate neo2 TAVR valve, comparing it to popular devices from Edwards Lifesciences and Medtronic.
READ MORE >

FDA gives AI-powered blood test for obstructive CAD breakthrough device designation

The FDA clearly sees significant potential in a new multi-protein blood test from Prevencio. The company's goal is to gain full approval and get the test in the hands of emergency departments all over the United States.

READ MORE >
blood test research laboratory
Share on Twitter Share on Facebook Share on Linkedin

FDA gives AI-powered blood test for obstructive CAD breakthrough device designation

Share on Twitter Share on Facebook Share on Linkedin
blood test research laboratory
The FDA clearly sees significant potential in a new multi-protein blood test from Prevencio. The company's goal is to gain full approval and get the test in the hands of emergency departments all over the United States.
READ MORE >

In Case You Missed It

PFA associated with elevated risk of heart damage, real-world data show

Patient outcomes do not appear to be negatively impacted by these risks, researchers noted. The new data were presented at Heart Rhythm 2025 and published in JACC: Clinical Electrophysiology.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

PFA associated with elevated risk of heart damage, real-world data show

Share on Twitter Share on Facebook Share on Linkedin
Patient outcomes do not appear to be negatively impacted by these risks, researchers noted. The new data were presented at Heart Rhythm 2025 and published in JACC: Clinical Electrophysiology.
READ MORE >

Champagne could be good for the heart—and other lessons from a new risk analysis

Researchers explored the potential impact of more than 100 risk factors on a person's risk of sudden cardiac arrest. Some of their findings were what you may expect, but others were much more surprising.

READ MORE >
drink champagne alcohol
Share on Twitter Share on Facebook Share on Linkedin

Champagne could be good for the heart—and other lessons from a new risk analysis

Share on Twitter Share on Facebook Share on Linkedin
drink champagne alcohol
Researchers explored the potential impact of more than 100 risk factors on a person's risk of sudden cardiac arrest. Some of their findings were what you may expect, but others were much more surprising.
READ MORE >

Exploring the evolution of AI in cardiology

Partho Sengupta, MD, shared his perspective on the current state of artificial intelligence in cardiology. The technology continues to evolve, he said, though it does still face certain limitations.

READ MORE >
Partho Sengupta, MD, DM, FACC, FASE, Henry Rutgers Professor of Cardiology and Chief of Cardiovascular Medicine, at Robert Wood Johnson Medical School, and Chief of the Cardiovascular Service Line at Robert Wood Johnson University Hospital, offers an overview of the current state of artificial intelligence (AI) in cardiology. He offers insights from what he has seen from some of the more than 160 FDA-cleared algorithms specific to cardiovascular medicine and what is in development.
Share on Twitter Share on Facebook Share on Linkedin

Exploring the evolution of AI in cardiology

Share on Twitter Share on Facebook Share on Linkedin
Partho Sengupta, MD, DM, FACC, FASE, Henry Rutgers Professor of Cardiology and Chief of Cardiovascular Medicine, at Robert Wood Johnson Medical School, and Chief of the Cardiovascular Service Line at Robert Wood Johnson University Hospital, offers an overview of the current state of artificial intelligence (AI) in cardiology. He offers insights from what he has seen from some of the more than 160 FDA-cleared algorithms specific to cardiovascular medicine and what is in development.
Partho Sengupta, MD, shared his perspective on the current state of artificial intelligence in cardiology. The technology continues to evolve, he said, though it does still face certain limitations.
READ MORE >

In Other News

Rite Aid closing distribution center and 68 stores

A week after filing Chapter 11 bankruptcy, the liquidation of Rite Aid's remaining assets has begun. 

READ MORE >
artificial intelligence pharmaceutical industry
Share on Twitter Share on Facebook Share on Linkedin

Rite Aid closing distribution center and 68 stores

Share on Twitter Share on Facebook Share on Linkedin
artificial intelligence pharmaceutical industry
A week after filing Chapter 11 bankruptcy, the liquidation of Rite Aid's remaining assets has begun. 
READ MORE >

Amazon One Medical employees viewed health data of man in wrongful death case

One Medical, a chain of primary care clinics owned by Amazon, is being sued by the family of a man who died due to alleged provider negligence. Now, court filings reveal staff improperly accessed the deceased man's protected medical records.

READ MORE >
Amazon is acquiring One Medical in a $3.9 billion deal
Share on Twitter Share on Facebook Share on Linkedin

Amazon One Medical employees viewed health data of man in wrongful death case

Share on Twitter Share on Facebook Share on Linkedin
Amazon is acquiring One Medical in a $3.9 billion deal
One Medical, a chain of primary care clinics owned by Amazon, is being sued by the family of a man who died due to alleged provider negligence. Now, court filings reveal staff improperly accessed the deceased man's protected medical records.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

The pros & cons of direct-to-patient drug programs | Why PAD patients should listen to their doctors
Coffee linked to major heart risk | Ablations in ASCs | Catheters recalled | A closer look at PFA | GLP-1 drugs & AFib
New guidelines for cardiovascular-kidney-metabolic syndrome and M-TEER | HF cell therapy company raises $4.4 million
Cardiac robotic surgery on patient 12,500 miles away | $13M for Star Trek actor HF malpractice case | New leadless pacemaker
Supreme Court sides supports cardiac drug maker | X-ray assesses pulmonary valve regurgitation | Making cardiac data actionable
Week in Review: Former ACC president dies | Administration questions vascular care | Is coffee bad for the heart | FFR-CT guide
New-look pacemaker uses ultrasound to stimulate the heart | Heartflow reports significant revenue growth | CCTA & CTO PCI

Pagination

    • First page « First
    • Previous page ‹‹
    • Page 1
    • Page 2
    • Page 3
    • Current page 4
    • Page 5
    • Page 6
    • Page 7
    • Page 8
    • Page 9 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme
Trimed Popup